Champions Oncology, Inc. (CSBR) vs Outset Medical, Inc. (OM)
A side-by-side comparison of Champions Oncology, Inc. and Outset Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CSBR
Champions Oncology, Inc.
$5.02HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT
OM
Outset Medical, Inc.
$4.13HealthcareDelayed quote: Oct 6, 2026, 1:48 PM EDT
Total return — CSBR vs OM
growth of $100 · dividends reinvested · last 6yCSBR -29.5% (-5.7%/yr)OM -99.5% (-59.4%/yr)CSBR compounded faster over this window
Log scale — wide-divergence pair
CSBR OM
CSBR vs OM: by the numbers
- •OM is the larger company ($76M vs $70M market cap).
- •Both run net losses; CSBR's is the smaller (-1.87% vs -63.06% net margin).
- •OM grew revenue faster over the past five years (8.28% vs 7.25% CAGR).
Metrics side by side
Valuation
| Metric | CSBR | OM |
|---|---|---|
| Forward P/E | 50.20 | N/A |
| P/S ratio | 1.15 | 0.65 |
| P/B ratio | 17.92 | 0.79 |
| EV / EBITDA | 262.40 | N/A |
Profitability
| Metric | CSBR | OM |
|---|---|---|
| Gross margin | 49.30% | 41.76% |
| Operating margin | -1.72% | -56.06% |
| Net margin | -1.87% | -63.06% |
| ROE | -29.15% | -77.12% |
| ROIC | -6.75% | -33.27% |
Growth (annualized)
| Metric | CSBR | OM |
|---|---|---|
| Revenue CAGR (5Y) | 7.25% | 8.28% |
| Total return CAGR (5Y) | -13.07% | -64.47% |
Frequently asked
- Which has grown faster, CSBR or OM?
- Over the past five years, OM grew revenue faster — CSBR at a 7.25% CAGR versus OM at 8.28%.
- How have CSBR and OM total returns compared?
- Over the past 5 years, CSBR delivered -13.07% and OM delivered -64.47% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.